ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 112 filers reported holding ENZO BIOCHEM INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $90,000 | -43.0% | 32,250 | -16.1% | 0.00% | 0.0% |
| Q3 2018 | $158,000 | +6.0% | 38,438 | +33.5% | 0.00% | 0.0% |
| Q2 2018 | $149,000 | -0.7% | 28,800 | +5.5% | 0.00% | 0.0% |
| Q1 2018 | $150,000 | +167.9% | 27,300 | +442.1% | 0.00% | – |
| Q2 2017 | $56,000 | -79.3% | 5,036 | -84.5% | 0.00% | -100.0% |
| Q1 2017 | $271,000 | +2.7% | 32,400 | -15.0% | 0.00% | 0.0% |
| Q4 2016 | $264,000 | +261.6% | 38,100 | +166.4% | 0.00% | – |
| Q3 2016 | $73,000 | -66.4% | 14,300 | -60.7% | 0.00% | -100.0% |
| Q2 2016 | $217,000 | +193.2% | 36,400 | +123.3% | 0.00% | 0.0% |
| Q1 2016 | $74,000 | -43.1% | 16,300 | -43.6% | 0.00% | 0.0% |
| Q4 2015 | $130,000 | +2066.7% | 28,900 | +1345.0% | 0.00% | – |
| Q3 2015 | $6,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |